You're Registered for the Webinar!
You're all set for Navigating Ames-Positive Results: Regulatory Guidance, Practical Considerations, and Strategic Approaches on April 9th, 2025 at 2:00 PM GMT+1 (9:00 AM EDT).
How to Prepare for the Webinar
To ensure a seamless experience, here are a few tips to get ready:
✅ Check Your Confirmation Email
GoToWebinar has sent a confirmation email from Scantox Webinars <customercare@gotowebinar.com> with your unique access link. If you don’t see it, check your spam folder or search for “GoToWebinar” in your inbox.
✅ Test Your Access in Advance
For the best experience, we recommend:
- Using Google Chrome or Firefox for optimal performance.
- Checking your system compatibility with GoToWebinar’s system test.
- Downloading the GoToWebinar desktop or mobile app if you prefer to join that way.
✅ Mark Your Calendar
We’ll send you a reminder one day before and one hour before the webinar, but adding it to your calendar now ensures you won’t miss it.
What to Expect
During this live session, our presenter will share practical considerations and strategic approaches for Ames-positive results, followed by a Q&A session where you can ask questions.
We look forward to having you join us! If you have any questions or technical issues, please contact us via email.
Enjoy The Webinar!
Grab a cup of your favorite beverage and settle in for this on-demand presentation of "Navigating Ames-Positive Results: Regulatory Guidance, Practical Considerations & Strategic Approaches" with our presenter Matt Tate, PhD, Managing Director at Gentronix, part of Scantox Group.
As the webinar is hosted on GoToStage, you may be prompted to re-enter your email to authenticate the session. This step simply enables playback and does not initiate any further communications.
Do you have questions about this presentation?
Feel free to contact us and we'll connect you with the presenter.
Discover How Scantox Can Support Your Program
Discovery
Scantox drives early-stage drug discovery with expert preclinical studies that de-risk development and fast-track innovation—specializing in therapies for metabolism, aging and neurological diseases.
Genetic Toxicology
Scantox offers a full suite of genetic toxicology services, including regulatory genotoxicity testing and skin sensitisation assessment, to support safety evaluation in drug development.
Regulatory Toxicology
Accelerate your path to approval with Scantox’s regulatory toxicology services—GLP-compliant studies tailored to your needs, with proven expertise in Göttingen Minipig safety assessments.
Pharmaceutical Development & Analytical
Scantox supports your Phase 1–2 trials with formulation development, manufacturing, and logistics—plus full bioanalysis services including LC-MS/MS method development, validation, and analysis.